Terbinafine Tablet
Product Images NDC 65862-079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 65862-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Terbinafine Fig1)

Figure 1 (Terbinafine Fig1)
Terbinafine Tablets, USP is a medication that contains 250mg of Terbinafine hydrochloride USP per tablet. It is usually prescribed to adults but the package insert should be referred to for dosage information. Dispensing of the medication guide provided separately for each patient is recommended. Terbinafine Tablets, USP should be stored at temperatures between 20°C to 25°C (68°F to 77°F). Excursions from this temperature range are allowed but not to exceed to 15°C to 30°C (59°F to 86°F). Protect Terbinafine Tablets, USP from light. This medication is distributed by Aurobindo Pharma USA, Inc. from East Windsor, NJ and is made in India. The product code is TS/DRUGS/19/1993.*
FDA Label Image

Chemical Structure (Terbinafine Str)

Chemical Structure (Terbinafine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.